Article

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

2021-01-21

Abstract excerpt

On May 8, 2020, Peru’s Ministry of Health approved ivermectin (IVM) for the treatment of COVID-19. A drug of Nobel Prize-honored distinction, IVM has been safely distributed in 3.7 billion doses worldwide since 1987. It has exhibited major, statistically significant reductions in case mortality and severity in 11 clinical trials for COVID-19, three with randomized controls. The indicated biological mechanism of IV...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2aa4e07b-c6b1-5094-bb1c-cc1834449bb3
DOI: 10.2139/ssrn.3765018

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin TreatmentsDOI 10.2139/ssrn.3765018Read

THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity Read

A retrospective analysis of COVID-19 non-pharmaceutical interventions for Mexico and Peru: a modeling studySemantic proximity Read

Covid-19 in Latin America countries: Course of the pandemic and the different responses towards controlSemantic proximity Read

Differential profile of Leptospirosis in patients under and over 5 years of age in health centers of the Peruvian Amazon, 2023–2024Semantic proximity Read

Minimal impact of ivermectin on immune response and transcriptional profiles in naïve adults with mild COVID-19Semantic proximity Read

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replicationSemantic proximity Read

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialSemantic proximity Read

Clinical and epidemiological characteristics among probable and confirmed patients with mpox in Sierra Leone reported from January to May 2025Semantic proximity Read

Simulación de escenarios para predecir el comportamiento de la COVID-19 en PerúSemantic proximity Read

(Hydroxy-) Chloroquine, G6PD deficiency, and sex differences in mortality during the COVID-19 pandemic: An ecological study in PeruSemantic proximity Read

Spreading of COVID-19 in Brazil: Impacts and uncertainties in social distancing strategiesSemantic proximity Read